• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃食管反流病中幽门螺杆菌感染率降低

Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease.

作者信息

Varanasi R V, Fantry G T, Wilson K T

机构信息

Department of Medicine, University of Maryland School of Medicine, and Baltimore Veterans Affairs Medical Center, 21201, USA.

出版信息

Helicobacter. 1998 Sep;3(3):188-94. doi: 10.1046/j.1523-5378.1998.08001.x.

DOI:10.1046/j.1523-5378.1998.08001.x
PMID:9731990
Abstract

BACKGROUND

An increased incidence of reflux esophagitis has been reported after eradication of H. pylori in patients with duodenal ulcer. To determine if H. pylori is associated with lower rates of esophagitis, we studied the prevalence of H. pylori infection in patients with and without reflux esophagitis and a subgroup of patients with concomitant peptic ulcer disease.

METHODS

Patients who underwent esophagogastroduodenoscopy and had diagnostic testing for H. pylori over a 30-month period were studied. H. pylori infection was determined by rapid urease testing, gastric histopathology, or serology. Reflux esophagitis was determined by endoscopic and/or histologic criteria.

RESULTS

Of 514 patients, 39.5% had H. pylori infection and 22.2% had reflux esophagitis. The prevalence of H. pylori infection in patients with reflux esophagitis was 30.7%, compared with 42.0% in patients without esophagitis (p = 0.039). The odds ratio for esophagitis risk with H. pylori infection was 0.61 (95% CI, 0.39-0.95). Neither patient age nor gender affected H. pylori prevalence. In patients with duodenal ulcer, H. pylori was present in 36.4% of patients with esophagitis and in 69.2% of patients without esophagitis (p = 0.018). The odds ratio for esophagitis with H. pylori infection in these patients was 0.25 (95% CI, 0.09-0.73).

CONCLUSIONS

Our study demonstrates that H. pylori infection is significantly less prevalent in patients with reflux esophagitis and may protect against its development. In duodenal ulcer patients, this effect was more dramatic. Further study is required to confirm these findings and elucidate mechanisms underlying possible beneficial effects of H. pylori.

摘要

背景

据报道,十二指肠溃疡患者根除幽门螺杆菌后反流性食管炎的发病率增加。为了确定幽门螺杆菌是否与食管炎发生率较低有关,我们研究了有反流性食管炎和无反流性食管炎患者以及伴有消化性溃疡疾病患者亚组中幽门螺杆菌感染的患病率。

方法

对在30个月期间接受食管胃十二指肠镜检查并进行幽门螺杆菌诊断检测的患者进行研究。通过快速尿素酶试验、胃组织病理学或血清学确定幽门螺杆菌感染情况。根据内镜和/或组织学标准确定反流性食管炎。

结果

514例患者中,39.5%有幽门螺杆菌感染,22.2%有反流性食管炎。反流性食管炎患者中幽门螺杆菌感染的患病率为30.7%,无食管炎患者为42.0%(p = 0.039)。幽门螺杆菌感染导致食管炎风险的比值比为0.61(95%可信区间,0.39 - 0.95)。患者年龄和性别均不影响幽门螺杆菌患病率。在十二指肠溃疡患者中,食管炎患者中有36.4%存在幽门螺杆菌,无食管炎患者中有69.2%存在幽门螺杆菌(p = 0.018)。这些患者中幽门螺杆菌感染导致食管炎的比值比为0.25(95%可信区间,0.09 - 0.73)。

结论

我们的研究表明,反流性食管炎患者中幽门螺杆菌感染的患病率显著较低,且可能预防其发生。在十二指肠溃疡患者中,这种作用更为显著。需要进一步研究来证实这些发现并阐明幽门螺杆菌可能有益作用的潜在机制。

相似文献

1
Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease.胃食管反流病中幽门螺杆菌感染率降低
Helicobacter. 1998 Sep;3(3):188-94. doi: 10.1046/j.1523-5378.1998.08001.x.
2
Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.190名对照受试者以及236名患有胃食管反流、糜烂性食管炎或巴雷特食管的患者中幽门螺杆菌感染的患病率。
Dis Esophagus. 1997 Jan;10(1):38-42. doi: 10.1093/dote/10.1.38.
3
Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?幽门螺杆菌根除与胃食管反流病有关吗?
Am J Gastroenterol. 2000 Apr;95(4):914-20. doi: 10.1111/j.1572-0241.2000.01929.x.
4
Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.1990年至1998年间悉尼西部地区消化性溃疡疾病和幽门螺杆菌感染减少,但反流性食管炎增加。
Dig Dis Sci. 2001 Dec;46(12):2716-23. doi: 10.1023/a:1012731614075.
5
[Helicobacter pylori eradication and gastroesophageal reflux disease: a Meta-analysis].[幽门螺杆菌根除与胃食管反流病:一项Meta分析]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):710-6. doi: 10.3760/cma.j.issn.0578-1426.2016.09.011.
6
[Helicobacter pylori gastric infection is a protection factor for gastroesophageal reflux disease].幽门螺杆菌胃部感染是胃食管反流病的一个保护因素。
Rev Gastroenterol Mex. 2002 Jan-Mar;67(1):22-7.
7
[Effects of Helicobacter pylori eradication on gastroesophageal reflux in patients with duodenal ulcer].[幽门螺杆菌根除对十二指肠溃疡患者胃食管反流的影响]
Rev Med Chil. 2002 Feb;130(2):153-9.
8
The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.日本巴雷特食管患者中幽门螺杆菌感染率及胃酸分泌状况
Am J Gastroenterol. 2004 Jul;99(7):1213-21. doi: 10.1111/j.1572-0241.2004.30313.x.
9
Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers.健康日本年轻志愿者幽门螺杆菌感染及内镜下反流性食管炎的危险因素
Intern Med. 2017 Nov 15;56(22):2979-2983. doi: 10.2169/internalmedicine.8669-16. Epub 2017 Sep 25.
10
Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease.糜烂性反流性食管炎疾病中幽门螺杆菌vacAs1a、cagA阳性和babA2阳性基因型感染的患病率较低。
Helicobacter. 2005 Dec;10(6):577-85. doi: 10.1111/j.1523-5378.2005.00363.x.

引用本文的文献

1
Relationship Among , Lower Esophagus Sphincter Pressure, and Gastroesophageal Reflux: A Single-Center Experience.食管下括约肌压力与胃食管反流之间的关系:单中心经验
Sisli Etfal Hastan Tip Bul. 2022 Sep 22;56(3):408-413. doi: 10.14744/SEMB.2022.55476. eCollection 2022.
2
Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.小檗碱通过抑制促炎细胞因子来预防反流性食管炎中的食管黏膜损伤。
Exp Ther Med. 2013 Sep;6(3):663-670. doi: 10.3892/etm.2013.1202. Epub 2013 Jul 4.
3
Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis.
幽门螺杆菌诱导的免疫失调和胃癌发生中的精氨酸和多胺。
Amino Acids. 2012 Feb;42(2-3):627-40. doi: 10.1007/s00726-011-1038-4. Epub 2011 Aug 28.
4
Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production.多胺通过抑制一氧化氮产生所需的 L-精氨酸摄取来损害对幽门螺杆菌的免疫力。
Gastroenterology. 2010 Nov;139(5):1686-98, 1698.e1-6. doi: 10.1053/j.gastro.2010.06.060. Epub 2010 Jul 1.
5
Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium.多中心联盟中不同种族群体复杂胃食管反流病和巴雷特食管的患病率
Dig Dis Sci. 2009 May;54(5):964-71. doi: 10.1007/s10620-009-0742-3. Epub 2009 Mar 3.
6
Comparing the acid-suppressive effects of three brands of generic lansoprazole with the original: pharmacokinetic bioequivalence tests do not necessarily guarantee pharmacodynamic equivalence.比较三种品牌的兰索拉唑仿制药与原研药的抑酸效果:药代动力学生物等效性试验不一定能保证药效学等效。
Dig Dis Sci. 2009 Nov;54(11):2385-90. doi: 10.1007/s10620-008-0634-y. Epub 2008 Dec 18.
7
L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori.L-精氨酸的可利用性调节诱导型一氧化氮合酶依赖性宿主对幽门螺杆菌的防御。
Infect Immun. 2007 Sep;75(9):4305-15. doi: 10.1128/IAI.00578-07. Epub 2007 Jun 11.
8
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.每日一次服用10毫克奥美拉唑与每日两次服用20毫克法莫替丁相比,哪种药物的抑酸效果更佳?对日本细胞色素P450 2C19基因野生型幽门螺杆菌阴性患者单次或重复给药的效果。
Dig Dis Sci. 2007 Feb;52(2):390-5. doi: 10.1007/s10620-006-9490-9. Epub 2007 Jan 9.
9
Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.白细胞介素1B促炎基因型通过诱导胃体萎缩预防胃食管反流病。
Gut. 2006 Feb;55(2):158-64. doi: 10.1136/gut.2005.072942. Epub 2005 Aug 24.
10
Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project.幽门螺杆菌感染及其根除对烧心和胃食管反流影响的随机对照试验:布里斯托尔幽门螺杆菌项目
BMJ. 2004 Jun 12;328(7453):1417. doi: 10.1136/bmj.38082.626725.EE. Epub 2004 May 4.